Eisai

Asia
Pharma

FDA safety probe, Otsuka, ADC patent fight—Fierce Pharma Asia

Takeda's Adzynma is under an FDA safety probe. Otsuka snagged a first-in-class FDA approval in IgAN. Daiichi one-ups Pfizer in their ADC patent fight.
Angus Liu Dec 5, 2025 8:45am
newspaper

Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia

Oct 31, 2025 8:20am
Golfer devastated after just barely missing a putt

Merck, Eisai call it quits on Keytruda-Lenvima in liver cancer type

Oct 29, 2025 11:32am
A close-up view of a jigsaw puzzle with a missing piece
Favicon Fierce Biotech

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
newspaper

Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia

Sep 5, 2025 9:00am
Leqembi IQLIK LEQEMBI IQLIK Eisai Biogen Leqembi

Eisai scores FDA nod for subcutaneous Leqembi maintenance dose

Aug 29, 2025 5:55pm